Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Lundbeck

Market Cap 4.02TCr 616.46Cr 537.49Cr 497.8Cr 466.01Cr 873.97Cr 58TCr 879.26Cr 5.91TCr 2.29TCr 29TCr 2.31TCr 2.26TCr 99TCr P/E 2026 *
9.34x
P/E 2027 * 9.14x
Enterprise Value 4.43TCr 679.34Cr 592.32Cr 548.58Cr 513.54Cr 963.12Cr 64TCr 968.95Cr 6.51TCr 2.52TCr 32TCr 2.55TCr 2.5TCr 1,09600Cr EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.56x
Free-Float
30.76%
Yield 2026 *
3.5%
Yield 2027 * 3.58%
1 day+0.28%
1 week-1.35%
Current month-0.54%
1 month+4.57%
3 months+6.40%
6 months+3.98%
Current year+1.10%
1 week 35.65
Extreme 35.65
36.85
1 month 35
Extreme 35
37.55
Current year 31.4
Extreme 31.4
39.9
1 year 28.5
Extreme 28.5
39.9
3 years 23.3
Extreme 23.3
41.7
5 years 21.94
Extreme 21.935
41.7
10 years 21.94
Extreme 21.935
41.7
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 49 01/09/2022
Chief Operating Officer 52 -
Director TitleAgeSince
Director/Board Member 67 25/03/2015
Director/Board Member 66 25/03/2015
Director/Board Member 60 20/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.38%-1.35% - - 621.42Cr
-3.74%-4.64%+2.98%+84.79% 8.79TCr
-1.99%+0.28%+34.08%+143.04% 5.19TCr
-1.78%+2.60%-14.81%+224.71% 2.27TCr
-1.24%-2.03%-9.60%-26.78% 796.37Cr
+2.31%-2.71%-31.28%-32.89% 735.22Cr
-2.73%-2.50%-10.78%-36.88% 652.2Cr
+1.32%-0.59%-1.98%+17.35% 515.5Cr
+1.47%+2.11%-5.48%-13.58% 356.28Cr
+2.15%-3.37%+9.30%+9.58% 322.6Cr
Average -0.44%-0.72%-3.06%+41.04% 2.18TCr
Weighted average by Cap. -2.29%+0.72%+6.72%+98.62%

Financials

2026 *2027 *
Net sales 2.57TCr 394.38Cr 343.86Cr 318.47Cr 298.13Cr 559.12Cr 37TCr 562.51Cr 3.78TCr 1.46TCr 18TCr 1.48TCr 1.45TCr 64TCr 2.57TCr 394.87Cr 344.28Cr 318.86Cr 298.5Cr 559.81Cr 37TCr 563.2Cr 3.78TCr 1.47TCr 18TCr 1.48TCr 1.45TCr 64TCr
Net income 471.05Cr 72Cr 63Cr 58Cr 55Cr 102.47Cr 6.82TCr 103.09Cr 692.38Cr 268.34Cr 3.36TCr 271.3Cr 265.48Cr 12TCr 480.71Cr 74Cr 64Cr 60Cr 56Cr 104.57Cr 6.96TCr 105.2Cr 706.57Cr 273.84Cr 3.43TCr 276.86Cr 270.92Cr 12TCr
Net Debt 409.82Cr 63Cr 55Cr 51Cr 48Cr 89Cr 5.93TCr 90Cr 602.38Cr 233.46Cr 2.92TCr 236.04Cr 230.97Cr 10TCr -3.01Cr -46.15L -40.24L -37.27L -34.89L -65.43L -44Cr -65.83L -4.42Cr -1.71Cr -21Cr -1.73Cr -1.7Cr -74Cr
Logo Lundbeck
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.
Employees
5,000
Date Price Change Volume
19/26/19 36.60 kr +2.38% 3,00,432
18/26/18 35.75 kr -0.28% 92,152
17/26/17 35.85 kr -0.14% 22,894
16/26/16 35.90 kr -1.78% 56,002
15/26/15 36.55 kr 0.00% 62,560
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
41.52DKK
Average target price
47.21DKK
Spread / Average Target
+13.70%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!